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Abstract
The model of bioﬁlm infection was ﬁrst proposed over a decade ago. Recent scientiﬁc advances have added much to our understanding
of bioﬁlms, usually polymicrobial communities, which are commonly associated with chronic infection. Metagenomics has demonstrated
that bacteria pursuing a bioﬁlm strategy possess many mechanisms for encouraging diversity. By including multiple bacterial and/or fungal
species in a single community, bioﬁlms obtain numerous advantages, such as passive resistance, metabolic cooperation, byproduct inﬂu-
ence, quorum sensing systems, an enlarged gene pool with more efﬁcient DNA sharing, and many other synergies, which give them a
competitive advantage. Routine clinical cultures are ill-suited for evaluating polymicrobial infections. DNA methods utilizing PCR meth-
ods, PCR/mass spectroscopy and sequencing have demonstrated their ability to identify microorganisms and quantitate their contribu-
tion to bioﬁlms in clinical infections. A more robust model of bioﬁlm infection along with more accurate diagnosis is rapidly translating
into improved clinical outcomes.
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Introduction
It has been over a decade since Costerton and Stewart [1] pro-
posed a simple model of bioﬁlm infection.The evolving bioﬁlm
infection paradigm was a signiﬁcant departure from the then
widely held view of infection, which envisioned single-species
bacteria in a planktonic mode of growth utilizing virulence fac-
tors to cause infection [2,3]. This planktonic view of infection
could explain most acute infections, but was wholly inadequate
for understanding chronic infections. However, Costerton
and Stewart’s early innovative bioﬁlm model of infection
demonstrated, at the biochemical and cellular levels, a new bac-
terial strategy by which communities of bacteria produce
infection.
Their bioﬁlm model of infection explained the ineffective-
ness of antibodies [4] and white blood cells [5] in combating
bioﬁlms. Other work showed the ineffectiveness of antibiot-
ics for clearing a bioﬁlm infection [6]. The ﬁnal thread was
the bioﬁlm’s ability to induce host hyperinﬂammation, as
shown by elevated levels of proinﬂammatory cytokines [7]
and matrix metalloproteases [8], and excessive numbers of
neutrophils [9].
Over the last decade, many new studies utilizing an
emerging and sophisticated science have generated a wealth
of fresh insights into the nature of bioﬁlm infection. It is
hoped that, through weaving of these different threads of
new information into the original bioﬁlm model of infection,
a robust tapestry will emerge that will allow for more
focused and productive research going forward.
Metagenome
Kim [10], in a recent review of the molecular pathways that
bacteria utilize for producing host infection, found that these
molecular pathways could be grouped into two different
types. One group of mechanisms was clearly for breaching
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the host tissue, producing cell death and necrosis for bacte-
rial nutrition. The other group comprised molecular mecha-
nisms by which bacteria could attach to host cells, and inject
small effector proteins that commandeered host cellular
pathways to reorganize the cellular cytoskeleton [11,12],
prevent migration [13], prevent mitosis [14] and, most
importantly, inhibit apoptosis [15–18]. This ‘new’ model of
infection encompasses the molecular strategies employed by
bioﬁlm phenotype bacteria.
Bacteria pursuing a bioﬁlm strategy for infection have
molecular mechanisms for recruiting other bacteria. It seems
that bioﬁlms actively attempt to become polymicrobial,
apparently to improve their survivability. There has been a
shift in microbiology into thinking of bioﬁlms as systems with
global regulation of the expanded gene pool provided by spe-
cies diversity [19]. This new understanding suggests that a
bioﬁlm is a single entity that exerts central control over the
individual members to yield the activities necessary for the
colony’s survival. Bioﬁlms require gene expression that
allows for attachment to the host, produces host cellular
senescence to prevent shedding, and causes local inﬂamma-
tion that creates plasma exudate for sustained colony nutri-
tion [20]. Microorganisms may combine their genetic
resources to fulﬁl these requirements, so that each individual
member of a bioﬁlm need not possess all of the genes neces-
sary to carry out each function. This has led to the proposal
of functional equivalent pathogroups, which are frequently
identiﬁed recurring groups of microorganisms in bioﬁlm
infections [21].
It has been demonstrated that, in Streptococcus pneumo-
niae, individual members of the community possess only a
proportion of all the genes present within the culture, and
this has led to the distributive genome hypothesis [3,22].
Sharing the total genes of the species (supragenome) allows
each member to expend less energy in maintaining its pro-
portion of the total gene pool, while allowing the entire
community to have all of the genes present [23]. Application
of this principle to polymicrobial bioﬁlms has led to the sug-
gestion that the genomic plurality leads to the continuous
production of novel strains, fostering a persistent infection
[24]. The main molecular method by which genomic plurality
is accomplished within the bioﬁlm is upregulated and highly
efﬁcient horizontal gene transfer [25,26].
In clearly deﬁned spatial locations within the bioﬁlm, hori-
zontal gene transfer is optimized by quorum sensing systems,
and is usually much more efﬁcient than the planktonic phe-
notype. Horizontal gene transfer, much more than vertical
gene transfer from the parent cell to the offspring, has been
reported to be the main mechanism for distributing genes
within prokaryotic bacteria [27,28]. The close spatial
arrangement of the community, along with quorum sensing,
allows for more efﬁcient DNA transfer among the members,
mainly through conjugation, occasionally through transforma-
tion, and rarely through bacteriophage-mediated transduction
[28]. Horizontal gene transfer is more efﬁcient in permissive
regions of the bioﬁlm and severely limited in regions of low/
no growth, owing to the accumulation of metabolic byprod-
ucts [29].
It has long been known that species diversity in ecological
systems provides greater ability to withstand various stres-
ses; this is known as the ‘insurance hypothesis’ [30]. Boles’s
group [31] took this one step further, showing that Pseudo-
monas aeruginosa, through a recA-dependent mechanism, self-
diversiﬁes its gene pool to become more recalcitrant in an
infection. So, whether by functional equivalence, a distribu-
tive genome, self-diversiﬁcation, or other methods, bioﬁlms
seek to expand their genetic diversity in order to ‘insure’
survival.
Synergies
Bioﬁlm communities in most environments, including human
disease, tend to be polymicrobial [32]. By including multiple
bacterial and/or fungal species in a single community, bioﬁlms
obtain numerous advantages, such as passive resistance [33],
metabolic cooperation [34,35], byproduct inﬂuence [36],
quorum sensing systems [34], an enlarged gene pool with
more efﬁcient DNA sharing [37], and many other synergies,
which give them a competitive advantage. It is best to view a
bioﬁlm as a single entity possessing multiple genetic
resources that allow it to adapt and thrive regardless of the
stresses that it encounters. In general, the greater the diver-
sity, i.e. the larger the gene pool, the more robust the bio-
ﬁlm is in terms of its survivability [38].
Individual bacteria possess multiple molecular mechanisms
to actively co-aggregate with other beneﬁcial species. Co-
aggregation mechanisms are usually reversible molecular
bonds that allow the genetically distinct bacteria to select for
beneﬁcial partners within the bioﬁlm [39]. Co-localization is
a similar concept, but carries the connotation of being a
more passive process. In co-localization, a species of bacteria
will encourage the local growth of a beneﬁcial partner by
providing beneﬁts for its growth rather than by utilizing
physical bonds.
Unique species of microorganisms that have the ability to
form bioﬁlms usually possess species-speciﬁc quorum sensing
molecules to direct the organization of the monoclonal bio-
ﬁlm. For polymicrobial bioﬁlms, there are some quorum
sensing molecules that can upregulate pathways in multiple
108 Clinical Microbiology and Infection, Volume 19 Number 2, February 2013 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, 107–112
species that are necessary for the individual constituents to
cooperate within the community. Autoinducer 2 is a small
boron-containing quorum sensing molecule that can be rec-
ognized by many different species of bacteria, including
anaerobes, Gram-negative bacteria, and Gram-positive bacte-
ria [40]. Autoinducer 2 has been shown to be present in
wound bioﬁlms, as well as in other chronic infections [41].
Similarly, it has been demonstrated that bacteria respond to
host molecules, such as adrenaline [42,43], and there is
growing evidence of bi-directional inter-kingdom signalling
[44]. The organisms in bioﬁlm infections possess the ability
to sense and respond to their neighbours and to their host
through multiple quorum sensing pathways.
Metabolic cross-feeding between genetically distinct spe-
cies has been well established. It has been shown that Strep-
tococcus gordonii produces peroxide that can cause
Aggregatibacter actinomycetemcomitans to produce a fac-
tor H-binding protein that limits the host’s ability to kill
A. actinomycetemcomitans through complement-mediated lysis
[45]. A. actinomycetemcomitans can utilize the lactic acid
byproduct of streptococcal metabolism, which not only ben-
eﬁts Streptococcus but also enhances the virulence of A. ac-
tinomycetemcomitans [46]. This metabolic cooperation has
been identiﬁed in numerous polymicrobial models [47–49].
The most common form of nutrient depletion within bio-
ﬁlms is the development of an anoxic region within the core
of the bioﬁlm [50]. In vitro bioﬁlm models have been
developed to exploit this property of bioﬁlms, to allow the
propagation of anaerobic bacteria in what is viewed as an oxy-
gen-rich environment, such as the surface of a chronic wound
[51]. Also, in vivo polymicrobial bioﬁlm models now allow the
evaluation of hypoxia, pH, and species interactions [48]. The
ability of bioﬁlms to provide an environment for anaerobic
growth through oxygen depletion may be an important factor
in the increase in the virulence of bioﬁlm infections [52–54].
Waste products, molecules that bacteria produce which
are end-products and are of no beneﬁt to the metabolizing
member, are released into the local bioﬁlm environment.
Many of these metabolites, such as ammonia, lactic acid, and
carbon dioxide, can have signiﬁcant inﬂuences on the sur-
rounding microorganisms [36]. Studies have demonstrated
that Fusobacterium nucleatum and Prevotella intermedia gener-
ate ammonia, which raises the pH to a level suitable for Por-
phyromonas gingivalis [55], and that F. nucleatum also increases
the level of carbon dioxide, which increases the pathogenic-
ity of P. gingivalis [56]. Also, it has been shown that waste
products from Pseudomonas aeruginosa may protect Staphylo-
coccus aureus from aminoglycosides [57].
Passive resistance occurs when one of the members in
the bioﬁlm possesses a resistance factor that can protect
other members of the bioﬁlm that do not have the factor.
There are numerous bioﬁlm defences that limit the effective-
ness of antibiotics. However, the easy sharing of mobile
genetic elements, such as mecA cassettes and genes encoding
extended-spectrum b-lactamases, raises concern about
increasing passive resistance in polymicrobial infections. For
example, a b-lactamase-producing strain of Haemophilus inﬂu-
enza was co-cultured with S. pneumoniae lacking any resis-
tance factors. H. inﬂuenza increased the MIC/MBC of
amoxycillin for S. pneumoniae [33].
The clinical concern about the synergies of polymicrobial
bioﬁlms is that the infection will be more severe and recalci-
trant to treatment. There are many examples showing that
this is indeed the case. Low levels of Pseudomonas aeruginosa
mixed with Staphylococcus aureus increased infection rates in
a rat model [58]. In a mouse model, Prevotella increases the
pathogenicity of Staphylococcus aureus [59]. Escherichia coli
produced a marked increase in the size of abscess formation
with Bacteroides fragilis in a diabetic mouse model [60]. There
is also clinical evidence suggesting that polymicrobial infec-
tions are more severe [38].
Diagnosing Polymicrobial Communities
The clinical signiﬁcance of shared genetic information, meta-
bolic synergies and co-aggregation/co-localization symbiosis is
that new diagnostic and therapeutic methods will be
required. Because, as discussed above, minor bacterial con-
stituents can provide a multitude of different advantages to
their neighbours, including increased virulence, it is impor-
tant to identify all of the species present and their relative
contributions to the infection. Clinical diagnostic methodolo-
gies are focused on identifying the most abundant organisms
producing an infection, but for bioﬁlms this will have to give
way to methods that can identify and quantitate each individ-
ual member of the polymicrobial community. Molecular
methods have demonstrated the ability to precisely deﬁne
the identity and quantity of each species of a polymicrobial
bioﬁlm infection [62–67].
The 16S rDNA has been called the genomic ﬁngerprint,
and molecular methods (PCR and sequencing) evaluating the
16S rDNA region are usually capable of reading this genomic
ﬁngerprint [62]. PCR methods are more suited to looking at
unique genetic targets within a particular species, but are
also used to evaluate the 16S rDNA [62]. However, the
speciﬁcity of PCR is a limitation, in that microorganisms can
only be identiﬁed if a speciﬁc primer is developed and vali-
dated. Because there are thousands of different species pres-
ent in bioﬁlm infections, this is currently impractical. To
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avoid the necessity of developing an almost inﬁnite number
of primers, innovators have integrated PCR of the bacterial
16S rDNA gene with rapid evaluation of this gene by mass
spectroscopy [68]. The Plex ID (Abbott Molecular) utilizes
multiple general primer sets to cover the different variable
regions of the 16S rDNA as well as other chromosomal and
plasmid regions, so that the vast majority of the currently
reported bacterial species can be identiﬁed [69]. By the use
of advanced mathematical algorithms, segments of the 16S
rDNA can be correlated with speciﬁc species with a very
high level of conﬁdence. This allows rapid same-day identiﬁ-
cation and some quantitation of the more prevalent organ-
isms within a polymicrobial infection [68].
Sequencing technologies such as pyrosequencing based on a
light signal (Roche 454), PacBio based on kinetic properties
(Paciﬁc Biosciences) and ion torrent based on pH signals (Life
Technologies) use different methods, but they all accurately
determine the sequences of long segments of speciﬁc regions of
bacterial DNA, such as the 16S rDNA gene. These technologies
can give a 99% accurate code for the 16S rDNA gene that is
then compared against accessible databases to identify the
microorganism with a high degree of certainty. The copy num-
ber for each speciﬁc organism can be compared with the total
number of copies for all organisms, providing good relative
quantiﬁcation for each microbial species present [70].
An issue is whether the bacterial DNA identiﬁed is from
bacteria that are alive. Ehrlich showed that ‘These ﬁndings
indicate that puriﬁed DNA and DNA from intact but nonvia-
ble bacteria do not persist in the middle ear cleft in the
presence of an effusion’ [71]. It therefore seems likely that
the majority of organisms identiﬁed by their DNA are indeed
viable organisms.
Molecular methods, even at this early stage, can handle
the challenges of correctly diagnosing polymicrobial infection.
Once good DNA is obtained, most molecular platforms are
extremely capable of accomplishing their analysis. However,
cleaning up of the data post-analysis, such as chimera check-
ing, noise suppression and data housekeeping after the run,
is critical. Reporting the identiﬁcation and amounts of the
organisms present requires complex bioinformatics to
reduce the massive amounts of data down to reliable, clini-
cally useful results. However, even with all of these technical
hurdles, molecular methods have demonstrated the unique
ability to reliably evaluate bioﬁlm infection [21,52,61,65,66].
Conclusion
Over 17 million people in the USA develop a chronic infec-
tion annually, and c. 500 000 people die with or from a
chronic infection each year [72]. This underscores the urgent
need for a deeper understanding of polymicrobial infection.
The amount and diversity of genetic material available to a
polymicrobial infection strongly inﬂuence the severity and
recalcitrance of the infection. Also, the interactions between
the available genes, competitive and/or synergistic, may pro-
vide important therapeutic targets in the near future. There-
fore, determining the species present and their relative
contributions to bioﬁlms, to understand and to exploit these
targets, is of great clinical importance. Far from being reduc-
tionist, by breaking bioﬁlms into their parts, molecular diag-
nostics provide a valuable clinical tool with which to truly
comprehend the mobile genetic elements, genes and syner-
gies that determine the behaviour of the unique bioﬁlm pro-
ducing a polymicrobial infection.
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